ALCHEMIA (ASX: ACL) is getting a new face.
The drug discovery and development company has announced the departure of Thomas Liquard as CEO.
In the interim, former ACL CEO Tracie Ramsdale will step up from a non-executive director role into an executive director capacity.
The company noted in an announcement that Ramsdale’s leadership will help them during this transition, and ended with thanking Liquard “for his efforts and wishing him well for the future”.
ALCHEMIA'S CEO DEPARTS
11 November 2014
)
Latest News
SavvyWise valuation hits $27.5m as accountants back AI tax platform’s $1.56m crowdfunding raise
Perth-based AI tax research platform SavvyWise has closed a $1.56 m...
The fluency trap: managing the most insidious risk in the AI era
In July last year, Deloitte Australia handed the federal government...
SkyCity strikes $21m deal with South Australia to settle Adelaide Casino regulatory failings
Auckland-headquartered casino operator SkyCity Entertainment Group ...
Brookfield offloads construction giant Multiplex to Japan's Obayashi for $924m after years of losses
Canadian investment group Brookfield has agreed to sell Australian-...
SpaceX listing fires up Pengana Private Equity Trust with estimated 18pc valuation boost
Sydney-based Pengana Investment Management has revealed that SpaceX...
)
Partner Content
For most Australian homeowners, the house gets the attention and the land gets taken fo...
Ventures & VisionariesAdvertisement
